Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Contributed by: GlobeNewswire

Tags

Ophthalmology

More Like This

Oblique Therapeutics today announced that Dr. Jan Lundberg has joined the company as Scientific Advisor

PR Newswire associated0

Adcendo ApS Announces Changes in Board of Directors and Strengthens Executive Leadership Team

Beacon Therapeutics Strengthens Leadership Team with the Appointment of Dr. Daniel Chung as Chief Medical Officer

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Appoints Ophthalmology Innovator, Eric D. Donnenfeld, MD as Medical Advisory Board Chair

Hansa Biopharma to Participate in H.C. Wainwright 26th Annual Global Investment Conference

Nordic Group B.V. Through Its Subsidiary Nordic Pharma, Inc. (U.S.), Appoints Renowned Oculoplastic Surgeon, John P. Fezza, MD to Its Medical Advisory Board

Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart)

Andreas Goppelt Appointed Managing Director of OrphaCare

Epsilogen Announces the Appointment of Cristina Oliva, MD, PhD as Chief Medical Officer